If you or someone close to you is living with relapsing forms of multiple sclerosis (MS), turn to BETAPLUS™. It’s the only MS support program that offers personalized B.E.T.A.† Nurse support to Betaseron® (Interferon beta-1b) patients and those considering Betaseron therapy. This support is available 24 hours a day, 7 days a week, 365 days a year.
Learn More About Latest MS News.
Contact a B.E.T.A. Nurse
Are you on Betaseron or considering Betaseron therapy? A B.E.T.A. nurse, specialized in MS, is available to you any time, day or night, to help answer your questions about MS and Betaseron. Call BETAPLUS at 1-800-788-1467 to talk to a B.E.T.A. nurse.
Click 'Play' to View the Real World Commercial
If you forgot your password click here.
New to BETAPLUS?
If you are a person with MS, or a family member, friend, well partner, or healthcare provider, and this is your first time visiting BETAPLUS, Register Now.
Attention BETAPLUS Members:
Has your address changed?
Update your
contact information here.
Sign up for free daily e-mail injection reminders
Learn more about using technology to help make the most of living with MS at
Living
with Passion - Read how Michael rode the wave to wellness.
†Betaseron Education, Training, and Assistance Nurse
Betaseron (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Important Safety Information
The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See “Warnings,” “Precautions,” and “Adverse Reactions” sections of full Prescribing Information.
